NEW YORK – Bio-Techne said this week that it has formed a joint venture company with Fresenius Kabi and Wilson Wolf to provide dedicated support to researchers and biopharmaceutical companies in the field of cell and gene therapy.
NEW YORK – Bio-Techne said this week that it has formed a joint venture company with Fresenius Kabi and Wilson Wolf to provide dedicated support to researchers and biopharmaceutical companies in the field of cell and gene therapy.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.